Literature DB >> 2445003

Relaxation of isolated human pulmonary muscle preparations with prostacyclin (PGI2) and its analogs.

I Haye-Legrand1, B Bourdillat, C Labat, J Cerrina, X Norel, J Benveniste, C Brink.   

Abstract

The effects of PGI2 and two analogs Iloprost and ZK 96480 were examined on isolated human pulmonary muscle preparations. High concentrations of these agents reduced the basal tone in all types of preparations. In addition, they relaxed tissues which had been maximally contracted with histamine (50 microM). PGI2 was more potent on pulmonary arterial muscle preparations (pD2 value: 6.33, n = 3) than on bronchial muscles. The relaxations induced by PGI2 in bronchial preparations were quite variable, that is, some tissues relaxed while others did not. The analogs also relaxed arterial preparations and the pD2 values were approximately the same (Iloprost: 7.42, n = 4 and ZK 96480: 7.48, n = 4). The isolated human pulmonary vascular preparations were approximately 10-fold more sensitive to the analogs than bronchial muscle preparations. In bronchial tissues we noted that the PGI2 relaxant effect was spontaneously reversed with time, an activity not observed with both analogs. A pretreatment of the bronchial tissues with indomethacin (1.7 microM) did not reduce the variations observed with PGI2 nor modify the transient relaxation observed with this agent. These data demonstrate that vascular tissues from the human lung are considerably more sensitive to these relaxant agonists than bronchial preparations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445003     DOI: 10.1016/0090-6980(87)90113-4

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  9 in total

1.  Bronchodilation induced by PGE2 is impaired in Group III pulmonary hypertension.

Authors:  Gulsev Ozen; Chabha Benyahia; Salma Mani; Kamel Boukais; Adam M Silverstein; Richard Bayles; Andrew C Nelsen; Yves Castier; Claire Danel; Hervé Mal; Lucie H Clapp; Dan Longrois; Xavier Norel
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

2.  Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations.

Authors:  R L Jones; H Wise; R Clark; R L Whiting; K R Bley
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

3.  Prostanoid receptors involved in the relaxation of human bronchial preparations.

Authors:  X Norel; L Walch; C Labat; J P Gascard; E Dulmet; C Brink
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Prostanoid receptors involved in the relaxation of human pulmonary vessels.

Authors:  L Walch; C Labat; J P Gascard; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.

Authors:  J E Merritt; A M Brown; S Bund; D G Cooper; J W Egan; T J Hallam; A M Heagerty; D M Hickey; A J Kaumann; M Keen
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

Review 6.  Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Authors:  S M Grant; K L Goa
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

7.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

8.  Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.

Authors:  N Foudi; L Kotelevets; L Louedec; G Leséche; D Henin; E Chastre; X Norel
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

9.  Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.

Authors:  Y M Qian; R L Jones; K M Chan; A I Stock; J K Ho
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.